{"date":"2025-09-26","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2025-09-26-1846-7abxec","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"18:46:01","subject":"公告本公司醫療長(CMO)異動","clause":"第11款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-09-26 18:46，「公告本公司醫療長(CMO)異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-09-26-1822-1662u6y","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"18:22:48","subject":"代重要子公司諾肯(股)公司公告114年6月6日第一次股東常會決議事項","clause":"第18款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-09-26 18:22，「代重要子公司諾肯(股)公司公告114年6月6日第一次股東常會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-09-26-1822-1pw6tvf","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"18:22:20","subject":"代重要子公司諾肯科技(股)公司公告114年員工認股權憑證轉換普通股之基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-09-26 18:22，「代重要子公司諾肯科技(股)公司公告114年員工認股權憑證轉換普通股之基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-09-26-1821-n8b0rb","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"18:21:24","subject":"代重要子公司諾肯科技(股)公司公告114年4月18日董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-09-26 18:21，「代重要子公司諾肯科技(股)公司公告114年4月18日董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-09-26-1803-1hamkig","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"18:03:36","subject":"本公司董事會通過重要子公司杏業生技(股)公司自地委建杏霖園區案","clause":"第20款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-09-26 18:03，「本公司董事會通過重要子公司杏業生技(股)公司自地委建杏霖園區案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-09-26-1755-1vwhr84","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"17:55:07","subject":"本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之公告標準","clause":"第23款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-09-26 17:55，「本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-09-26-1745-ku74db","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"17:45:18","subject":"公告本公司董事會通過國內第五次無擔保可轉換公司債之資金計畫用途變更","clause":"第16款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-09-26 17:45，「公告本公司董事會通過國內第五次無擔保可轉換公司債之資金計畫用途變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-09-26-1612-n1jkcn","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"16:12:50","subject":"公告本公司Hyaltouch各劑型皮下填補劑產品取得銷售許可證書","clause":"第51款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-09-26 16:12，「公告本公司Hyaltouch各劑型皮下填補劑產品取得銷售許可證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-09-26-1603-1o3nm8c","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"16:03:02","subject":"本公司董事會決議不繼續辦理民國113年第一次股東臨時會通過之私募現金增資發行普通股案","clause":"第14款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-09-26 16:03，「本公司董事會決議不繼續辦理民國113年第一次股東臨時會通過之私募現金增資發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-09-26-1558-sbd1so","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"15:58:29","subject":"公告本公司114年08月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-09-26 15:58，「公告本公司114年08月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-09-26-1544-1bi2fou","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"15:44:25","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-09-30","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-09-26 15:44，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-09-26-1540-1bi2fou","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"15:40:47","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-09-30","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-09-26 15:40，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-09-26-1514-1pzjlpi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-09-26","time":"15:14:53","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-09-26 15:14，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-09-26-1403-wr0tu2","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-09-26","time":"14:03:47","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-09-26 14:03，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-09-26-0015-xkc4nn","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-09-26","time":"00:15:35","subject":"補充公告本公司9/15召開重大訊息記者會新聞稿內容","clause":"第53款","fact_date":"2025-09-26","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-09-26 00:15，「補充公告本公司9/15召開重大訊息記者會新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}